Literature DB >> 19445941

Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin.

Yulia A Nevzorova1, Darjus Tschaharganeh, Nikolaus Gassler, Yan Geng, Ralf Weiskirchen, Piotr Sicinski, Christian Trautwein, Christian Liedtke.   

Abstract

BACKGROUND & AIMS: E-cyclins control the transition of quiescent cells into the cell cycle. Two E-cyclins, CcnE1 and CcnE2, have been described, but their specific contributions to cell cycle reentry in vivo are poorly understood. Liver regeneration following partial hepatectomy is an excellent in vivo model for the study of cell cycle reentry of quiescent cells. We investigated the relevance of E-cyclins in directing resting hepatocytes into the cell cycle after partial hepatectomy using CcnE1 and CcnE2 knockout mice.
METHODS: Partial hepatectomy (70%) was performed in CcnE1 (E1(-/-)) and CcnE2 (E2(-/-)) knockout and wild-type mice. Liver regeneration was monitored by cell cycle markers for G(1)/S phase, S phase, and M phase as well as by determining the liver/body weight ratio after partial hepatectomy. Ploidy of hepatocytes was determined by fluorescence-activated cell sorting and fluorescent in situ hybridization.
RESULTS: CcnE1 deletion resulted in normal liver regeneration with a slight delay of the G(1)/S-phase transition and a defect in endoreplication of otherwise polyploid hepatocytes. Surprisingly, E2(-/-) mice displayed accelerated and sustained DNA synthesis after partial hepatectomy, excessive endoreplication in hepatocytes, and a liver mass that was 45% greater than that of wild-type mice after termination of the regeneration process. CcnE2 depletion induced overexpression of CcnE1 and prolonged cdk2 kinase activity after partial hepatectomy.
CONCLUSIONS: CcnE2 has an unexpected role in repressing CcnE1; the phenotype of E2(-/-) mice appears to result from CcnE1 overexpression and cdk2 hyperactivation. CcnE1 and CcnE2 therefore have nonredundant functions for S-phase entry and endoreplication during liver regeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19445941      PMCID: PMC2730664          DOI: 10.1053/j.gastro.2009.05.003

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events.

Authors:  S H Sigal; P Rajvanshi; G R Gorla; R P Sokhi; R Saxena; D R Gebhard; L M Reid; S Gupta
Journal:  Am J Physiol       Date:  1999-05

Review 2.  Hepatic polyploidy and liver growth control.

Authors:  S Gupta
Journal:  Semin Cancer Biol       Date:  2000-06       Impact factor: 15.707

3.  Kinase-independent function of cyclin E.

Authors:  Yan Geng; Young-Mi Lee; Markus Welcker; Jherek Swanger; Agnieszka Zagozdzon; Joel D Winer; James M Roberts; Philipp Kaldis; Bruce E Clurman; Piotr Sicinski
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

4.  Constitutive turnover of cyclin E by Cul3 maintains quiescence.

Authors:  Justina D McEvoy; Uta Kossatz; Nisar Malek; Jeffrey D Singer
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

Review 5.  Cell cycle sibling rivalry: Cdc2 vs. Cdk2.

Authors:  Philipp Kaldis; Eiman Aleem
Journal:  Cell Cycle       Date:  2005-11-29       Impact factor: 4.534

6.  Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice.

Authors:  T Wüstefeld; T Rakemann; S Kubicka; M P Manns; C Trautwein
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

7.  Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes.

Authors:  Alejandro Soto-Gutiérrez; Naoya Kobayashi; Jorge David Rivas-Carrillo; Nalu Navarro-Alvarez; Debiao Zhao; Debaio Zhao; Teru Okitsu; Hirofumi Noguchi; Hesham Basma; Yashuhiko Tabata; Yong Chen; Kimiaki Tanaka; Michiki Narushima; Atsushi Miki; Tadayoshi Ueda; Hee-Sook Jun; Ji-Won Yoon; Jane Lebkowski; Noriaki Tanaka; Ira J Fox
Journal:  Nat Biotechnol       Date:  2006-11-05       Impact factor: 54.908

8.  Genetic substitution of Cdk1 by Cdk2 leads to embryonic lethality and loss of meiotic function of Cdk2.

Authors:  Ande Satyanarayana; Cyril Berthet; Javier Lopez-Molina; Vincenzo Coppola; Lino Tessarollo; Philipp Kaldis
Journal:  Development       Date:  2008-09-11       Impact factor: 6.868

9.  Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers.

Authors:  J M Gudas; M Payton; S Thukral; E Chen; M Bass; M O Robinson; S Coats
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 10.  From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway.

Authors:  Ang Sun; Luigi Bagella; Steven Tutton; Gaetano Romano; Antonio Giordano
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

View more
  33 in total

Review 1.  Endoreplication and polyploidy: insights into development and disease.

Authors:  Donald T Fox; Robert J Duronio
Journal:  Development       Date:  2013-01-01       Impact factor: 6.868

2.  Nucleoplasmic calcium regulates cell proliferation through legumain.

Authors:  Viviane Andrade; Mateus Guerra; Camila Jardim; Flavia Melo; Wamberto Silva; Jose M Ortega; Marie Robert; Michael H Nathanson; Fatima Leite
Journal:  J Hepatol       Date:  2011-01-13       Impact factor: 25.083

3.  RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats.

Authors:  Shirish Paranjpe; William C Bowen; George C Tseng; Jian-Hua Luo; Anne Orr; George K Michalopoulos
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

4.  CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.

Authors:  Erawan Borkham-Kamphorst; Claudia R van Roeyen; Eddy Van de Leur; Jürgen Floege; Ralf Weiskirchen
Journal:  J Cell Commun Signal       Date:  2011-07-05       Impact factor: 5.782

5.  Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.

Authors:  Roland Sonntag; Nives Giebeler; Yulia A Nevzorova; Jörg-Martin Bangen; Dirk Fahrenkamp; Daniela Lambertz; Ute Haas; Wei Hu; Nikolaus Gassler; Francisco Javier Cubero; Gerhard Müller-Newen; Ali T Abdallah; Ralf Weiskirchen; Fabio Ticconi; Ivan G Costa; Mariano Barbacid; Christian Trautwein; Christian Liedtke
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-27       Impact factor: 11.205

6.  Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice.

Authors:  Yulia A Nevzorova; Jörg-Martin Bangen; Wei Hu; Ute Haas; Ralf Weiskirchen; Nikolaus Gassler; Sebastian Huss; Frank Tacke; Piotr Sicinski; Christian Trautwein; Christian Liedtke
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

7.  Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.

Authors:  C Elizabeth Caldon; C Marcelo Sergio; Andrew Burgess; Andrew J Deans; Robert L Sutherland; Elizabeth A Musgrove
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

8.  Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.

Authors:  Haksier Ehedego; Antje Mohs; Bettina Jansen; Kanishka Hiththetiya; Piotr Sicinski; Christian Liedtke; Christian Trautwein
Journal:  Oncogene       Date:  2018-03-19       Impact factor: 9.867

Review 9.  Polyploidy in liver development, homeostasis and disease.

Authors:  Romain Donne; Maëva Saroul-Aïnama; Pierre Cordier; Séverine Celton-Morizur; Chantal Desdouets
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-02       Impact factor: 46.802

10.  Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer.

Authors:  C Elizabeth Caldon; Elizabeth A Musgrove
Journal:  Cell Div       Date:  2010-01-17       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.